摘要
目的分析来自医院感染患者标本的鲍曼不动杆菌的耐药性。方法对281株鲍曼不动杆菌进行药敏试验,药敏结果采用WHONET5.6软件进行回顾性分析。结果 2012年~2014年鲍曼不动杆菌对多黏菌素B敏感率一直为100%,对阿米卡星的敏感率分别为18.6%、37.1%和41.4%,对复方新诺明的敏感率分别为28.0%、38.1%和41.4%,3年对亚胺培南耐药率均高于69%,对美洛培南的耐药率均高于70%。结论来自医院感染患者标本的鲍曼不动杆菌对多黏菌素B敏感率高,对亚胺培南、美洛培南的耐药率高。
Objective To analyze the drug-resistance of Acinetobacter baumannii in the clinical infection. Methods The drug sensitive test was conducted in 281 bacterial isolates of Acinetobacter baumannii,and the results were retrospectively analyzed by software WHONET 5. 6. Results It was showed that in 2012,2013 and 2014 the sensitivity rates to polymyxin B of Acinetobacter baumannii were always 100%. The sensitivity rates to amikacin were 18. 6%,37. 1% and 41. 4%,respectively.The sensitivity rates to cotrimoxazole were 28. 0%,38. 1% and 41. 4%,respectively. In the last three years,the resistance rates to imipenem were all above 69% and meropenem were all above 70%. Conclusion There were high sensitivity rates of Acinetobacter baumannii to polymyxin B and high resistance rates to imipenem and meropenem.
出处
《山东医药》
CAS
北大核心
2015年第31期39-41,共3页
Shandong Medical Journal
基金
国家科技支撑计划基金资助项目(2012EP001000)
关键词
鲍曼不动杆菌
细菌耐药
抗菌药物
Acinetobacter baumannii
bacterial resistance
anti-bacterial agents